Representative image
HYDERABAD: After Bharat Biotech terminated its MoU with Brazilian partner Precisa Medicamentos on Friday, Brazil’s health regulator Anvisa (Agencia Nacional de Vigilancia Sanitaria) said it has suspended Covaxin’s clinical trials in Brazil. Precisa had submitted a request for randomised, double-blind and placebo-controlled phase-3 study of Covaxin in Brazil to Anvisa.
“The Coordination of Clinical Research determined this Friday the precautionary suspension of clinical studies of Covaxin in Brazil,” said a notice by Anvisa on website.
“The suspension was carried out as a result of a statement from the Indian company Bharat Biotech Limited International, sent to Anvisa on Friday (23/7). In the statement, Bharat informs that the company Necessidade Comercializacao de Medicamentos Ltda is no longer authorized to represent Bharat in Brazil, which in Anvisa’s assessment makes it impossible to carry out the study. Bharat is the manufacturer of the Cova
Brazil suspends clinical trials of Covaxin after Bharat Biotech terminates vaccine deal
Brazil suspends clinical trials of Covaxin after Bharat Biotech terminates vaccine deal
Bharat Biotech on Friday said it had terminated a memorandum of understanding to sell its Covid vaccine Covaxin to Brazil s Precisa Medicamentos.
advertisement
UPDATED: July 24, 2021 10:37 IST
Bharat Biotech on Friday said it terminated the Memorandum of Understanding with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its Covid-19 vaccine Covaxin. (Reuters photo)
Brazil has suspended the clinical studies of Bharat Biotech s Covid-19 vaccine Covaxin after termination of the company s agreement with its partner, as per reports.
Brazil suspends Bharat Biotech s Covaxin clinical trials thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
1085
Hyderabad, July 24
Brazil has suspended the clinical studies of Bharat Biotech’s Covid-19 vaccine, Covaxin following termination of the company’s agreement with its partner there, the South American Country’s health regulator said.
Bharat Biotech on Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market.
The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.
“In the Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil
Brazil suspends Covaxin clinical trials after Bharat Biotech cancels contracts with its partner
The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities.
Share Via Email
| A+A A- By PTI
HYDERABAD: Brazil has suspended the clinical studies of Bharat Biotech s COVID-19 vaccine, Covaxin following termination of the company s agreement with its partner there, the South American Country s health regulator said.
Bharat Biotech on Friday announced cancellation of the MoU it signed with Precisa Medicamentos and Envixia Pharmaceuticals LL.C for its COVID-19 vaccine Covaxin for the Brazilian market.